Damodar Kumbala, Rubin Zhang. Essential concept of transplant immunology for clinical practice
World J Transplant 2013 December 24; 3(4): 113-118
Doi: 10.5500/wjt.v3.i4.113
https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC3879520/pdf/WJT-3-113.pdf
Hricik DE. Transplant immunology and immunosuppression: core curriculum 2015.. doi: Am J Kidney Dis. 2015 Jun;65(6):956-66
DOI: 10.1053/j.ajkd.2015.01.026
https://www.ajkd.org/article/
S0272-6386(15)00512-0/fulltext
Ana Konvalinka and Kathryn Tinckam. Utility of HLA antibody testing in kidney transplantation.
J Am Soc Nephrol. 2015 Jul; 26(7): 1489–1502.
DOI: 10.1681/ASN.2014080837
https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4483594/
Tapiawala, Shruti, Jogale Suchita. Chapter 1- Immunobiology of Transplantatiand Evaluation Techniques.
Textbook for Kidney Transplantation, First Edition. 2023 Jaypee Brothers Medical Publishers: P 01 to 09
https://www.amazon.in/Textbook-Kidney-
Transplantation-Vinant-Bhargava-ebook/
dp/B0CDC8WJ2L/ref=tmm_kin_swatch_0?_
encoding=UTF8&qid=&sr=
Tinckam KJ, Chandraker A. Mechanisms and Role of HLA and non-HLA Alloantibodies
Clin J Am Soc Nephrol. 2006 May;1(3):404-14
DOI: 10.2215/CJN.00270106
Mechanisms and Role of HLA and
non-HLA Alloantibodies: Clinical Journal of
the American Society of Nephrology (lww.com)
Tapiawala, Shruti, Jogale, Suchita, Human Leukocyte Antigen Typing in Organ Transplantation: Methods, Clinical Relevance, and Practical Applications.
Indian Journal of Kidney Diseases 3(1):p 4-11, Jan–Mar 2024.
DOI: 10.4103/ijkd.ijkd_56_23
https://journals.lww.com/ijkd/fulltext/2024/03010/
human_leukocyte_antigen_typing_in_organ.2.aspx
Mahdi BM. A glow of HLA typing in organ transplantation.
Clin Transl Med. 2013 Feb 23;2(1):6.
DOI: 10.1186/2001-1326-2-6
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3598844/pdf/2001-1326-2-6.pdf
Sheldon S, Poulton K. HLA typing and its influence on organ transplantation.
Methods Mol Biol. 2006;333:157-74.
DOI: 10.1385/1-59745-049-9:157. PMID: 16790851
https://link.springer.com/protocol/
10.1385/1-59745-049-9:157
Jeethu Anu Geo, Reem Ameen, Salem A Shemmari, Jibu Thomas. Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine
Med Princ Pract March 5, 2024
DOI: 10.1159/000538176
https://karger.com/mpp/article-pdf/doi/
10.1159/000538176/4188926/000538176.pdf
Susan V. Fuggle, Craig J. Taylor. Histocompatibility in Renal Transplantation Kidney
Transplantation-Principles and Practice: Seventh Edition, Chapter 10
DOI:10.1016/B978-1-4557-4096-3.00010-6
Histocompatibility in Kidney Transplantation
(researchgate.net)
Mohanka R, El Kosi M, Jin JK, Sharma A and Halawa A. Careful Interpretation of HLA Typing and Cross-Match Tests in Kidney Transplant.
JOJ uro & nephron 3(5): pg 01-06
DOI: 10.19080/JOJUN.2017.03.555625
Careful Interpretation of HLA Typing and
Cross-Match Tests in Kidney Transplant (juniperpublishers.com)
Choo SY. The HLA system: genetics, immunology, clinical testing, and clinical implications.
Yonsei Med J. 2007 Feb 28;48(1):11-23.
DOI: 10.3349/ymj.2007.48.1.11.
YMJ 48-1.hwp (nih.gov)
Althaf MM, El Kossi M, Jin JK, Sharma A, Halawa AM. Human leukocyte antigen typing and crossmatch: A comprehensive review.
World J Transplant. 2017 Dec 24;7(6):339-348.
doi: 10.5500/wjt.v7.i6.339.
ncbi.nlm.nih.gov/pmc/articles/PMC5743871/pdf/WJT-7-339.pdf
Ramon Patel and Paul I. Terasaki. Significance of the Positive Crossmatch test in Kidney Transplantation
N Engl J Med 1969;280:735-739
Doi:(10.1056/NEJM196904032801401)
Significance of the Positive Crossmatch Test in Kidney
Transplantation | New England Journal of Medicine (nejm.org)
Zachary AA, Klingman L, Thorne N, Smerglia AR, Teresi GA. Variations of the Lymphocytotoxicity test: An evaluation of sensitivity and specificity.
Transplantation. 1995 Sep 15;60(5):498-503
Doi: 10.1097/00007890-199509000-00016
Variations of the lymphocytotoxicity test. An evaluation of
sensitivity and specificity – PubMed (nih.gov)
Colombo MB, Haworth SE, Poli F, Nocco A, Puglisi G, Innocente A, Serafini M, Messa P, Scalamogna M. Luminex technology for anti-HLA antibody screening: Evaluation of performance and impact on laboratory routine.
Cytometry B Clin Cytom. 2007 Nov;72(6):465-71.
Doi:10.1002/cyto.b.20353
Luminex technology for anti‐HLA antibody screening:
Evaluation of performance and of impact on laboratory
routine – Colombo – 2007 – Cytometry Part B:
Clinical Cytometry – Wiley Online Library
Mulley WR, Kanellis J. Understanding crossmatch testing in organ transplantation: A case-based guide for Nephrologist.
Nephrology (Carlton). 2011 Feb;16(2):125-33.
Doi: 10.1111/j.1440-1797.2010.01414.x
https://onlinelibrary.wiley.com/doi/
10.1111/j.1440-1797.2010.01414.x
Jaramillo A, Ramon DS, Stoll ST. Technical aspects of Crossmatching in Transplantation.
Clin Lab Med. 2018 Dec;38(4):579-593.
Doi: 10.1016/j.cll.2018.07.002
https://linkinghub.elsevier.com/retrieve/pii/S0272-2712(18)31163-6
The Clinical Importance of Flowcytometry Crossmatch in the context of CDC Crossmatch results.
Transplant Proceedings, 2010.
Doi: 10.1016/j.transproceed.2010.06.025
https://www.sciencedirect.com/science/article/
abs/pii/S004113451001290X?via%3Dihub
Downing J. The lymphocyte crossmatch by flow cytometry for kidney transplantation.
Methods Mol Biol. 2012;882:379-90.
DOI: 10.1007/978-1-61779-842-9_22.
https://link.springer.com/protocol/
10.1007/978-1-61779-842-9_22
Althaf MM, El Kossi M, Jin JK, Sharma A, Halawa AM. Human leukocyte antigen typing and crossmatch: A comprehensive review.
World J Transplant. 2017 Dec 24;7(6):339-348.
doi: 10.5500/wjt.v7.i6.339.
ncbi.nlm.nih.gov/pmc/articles/
PMC5743871/pdf/WJT-7-339.pdf
Osickova K, Hruba P, Kabrtova K, Klema J, Maluskova J, Slavcev A, Slatinska J, Marada T, Böhmig GA and Viklicky O (2021) Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Per transplant Desensitization.
Front. Med. 8 December 2021:780636.
DOI: 10.3389/fmed.2021.780636
Grażyna Moszkowska, Hanna Zielińska, Maciej Zieliński, Justyna Gołębiewska, Beata Bzoma, Justyna Sakowska, Alicja Dębska-Ślizień, Piotr Trzonkowski. The utility of cytolytic flow cytometry crossmatch before kidney transplantation,
Transplant Immunology, Volume 68, 2021, 101426,
DOI: 10.1016/j.trim.2021.101426.
https://www.sciencedirect.com/science/
article/abs/pii/S0966327421000666
Mohanka R, El Kosi M, Jin JK, Sharma A and Halawa A. Careful Interpretation of HLA Typing and Cross-Match Tests in Kidney Transplant.
JOJ uro & nephron 3(5): pg 01-06
DOI: 10.19080/JOJUN.2017.03.555625
Careful Interpretation of HLA Typing and Cross-Match
Tests in Kidney Transplant (juniperpublishers.com)
Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Hallar M, Markowitz GS, D’Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
Transpl Immunol. 2008 Nov;20(1-2):61-7.
Doi: 10.1016/j.trim.2008.09.013
https://www.sciencedirect.com/science/article/
abs/pii/S0966327408000877?via%3Dihub
Peng B, Zhuang Q, Yu M, Li J, Liu Y, Zhu L, Ming Y. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
Med Sci Monit. 2019 Feb 3; 25:952-961.
DOI: 10.12659/MSM.914902.
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC6369651/pdf/medscimonit-25-952.pdf
Chari M, Kosi ME, Jim JK, Sharma A, Halawa A. Crossmatching in Renal Transplantation by Non-Immunologists for Non-Immunologists.
Urol Nephrol Open Access J, 2017; 5(2): 00166.
DOI: 10.15406/unoaj.2017.05.00166
https://medcraveonline.com/
UNOAJ/UNOAJ-05-00166.pdf
Mahowald GK. The CDC crossmatch in the era of flow cytometric cross-match and single antigen beads.
J Bras Nefrol. 2021 Jul-Sep;43(3):299-300.
DOI: 10.1590/2175-8239-JBN-2021-0110.
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC8428642/pdf/2175-8239-jbn-2021-0110.pdf
Delgado JC, Eckels DD. Positive B-cell only flow-cytometry crossmatch: Implications for renal transplantation.
Exp Mol Pathol. 2008 Aug;85(1):59-63.
Doi: https://doi.org/10.1016/j.yexmp.2008.03.009
https://www.sciencedirect.com/science/article/abs/pii/S0014480008000324?via%3Dihub
Putheti P, Sharma VK, Friedlander R, Menon A, Dadhania D, Muthukumar T, Suthanthiran M. T-cell positive, B-cell negative Flow cytometry crossmatch: Frequency, HLA Locus specificity and mechanism among 3073 clinical flow cytometry crossmatch tests.
Exp Clin Transplant. 2022 Feb; 20(2):180-189.
Doi: 10.6002/ect.2021.0334.
http://www.ectrx.org/forms/ectrxcontentshow.php?
year=2022&volume=20&issue=2&supplement=0&makale_no
=0&spage_number=180&content_type=FULL%20TEXT
Mehra S, Tiwari AK, Aggarwal G, Arora D, Saini A, Rajvanshi C, Kumari P, Dorwal P. Discordance between Flow Cytometry crossmatch and Single Antigen Bead (SAB) assay: An uncommon finding and its resolution.
Indian J Nephrol. 2020 Jan-Feb; 30(1):55-57.
Doi: https://doi.org/10.4103%2Fijn.IJN_61_19
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC6977385/pdf/IJN-30-55.pdf
Zhang R. Donor specific antibodies in kidney transplant recipients
Clin J Am Soc Nephrol. 2018 Jan 6;13(1):182-192
DOI: 10.2215/CJN.00700117.
Donor-Specific Antibodies in Kidney
Transplant Recipients – PMC (nih.gov)
Picascia A, Infante T, Napoli C. Luminex and antibody detection in kidney transplantation.
Clin Exp Nephrol. 2012 Jun;16(3):373-81
Doi: 10.1007/s10157-012-0635-1
https://link.springer.com/article/10.1007/s10157-012-0635-1
Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
Nephrol Dial Transplant. 2006 Sep;21(9):2625-9.
Doi: 10.1093/ndt/gfl202
https://academic.oup.com/ndt/
article/21/9/2625/1938860?login=false
Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C. Intact HLA Not 2m-free Heavy Chain-Specific HLA Class I Antibodies Are Predictive of Graft Failure.
Transplantation. 2009 Jul 27;88(2):226-30.
Doi: 10.1097/TP.0b013e3181ac6198
https://journals.lww.com/transplantjournal/
fulltext/2009/07270/intact_hla_not__2m_free_
heavy_chain_specific_hla.12.aspx
Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, Lee JH, El-Awar N, Alberú J. “Natural” human leukocyte antigen antibodies in Non-immunised healthy males.
Transplantation. 2008 Oct 27;86(8):1111-5
Doi: 10.1097/TP.0b013e318186d87b
https://journals.lww.com/transplantjournal/
fulltext/2008/10270/_natural__human_leukocyte_
antigen_antibodies_found.15.aspx
Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL. The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.
Nephrol Dial Transplant. 2018 Oct 1;33(10):1853-1863.
Doi:10.1093/ndt/gfy088.
https://academic.oup.com/ndt/article/
33/10/1853/4973746?login=false
Sullivan HC, Liwski RS, Bray RA, Gebel HM. The Road to HLA antibody evaluation: Do not rely on MFI.
Am J Transplant. 2017 Jun;17(6):1455-1461.
Doi: 10.1111/ajt.14229
https://www.amjtransplant.org/article/
S1600-6135(22)25007-2/fulltext
Gebel HM, Bray RA. HLA antibody detection with solid phase assays: great expectations or expectations too great?
Am J Transplant. 2014 Sep;14(9):1964-75.
doi: 10.1111/ajt.12807.
HLA Antibody Detection With Solid Phase Assays:
Great Expectations or Expectations Too Great?
– ScienceDirect
Bettinotti MP, Zachary AA, Leffell MS. Clinically relevant interpretation of solid phase assays for HLA antibody.
Curr Opin Organ Transplant. 2016 Aug;21(4):453-8.
doi: 10.1097/MOT.0000000000000326.
Clinically relevant interpretation of solid phase
assays for HLA antibody – PMC (nih.gov)
Lachmann N, Todorova K, Schulze H, Schönemann C. Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion.
Transfus Med Hemother. 2013 Jun;40(3):182-9.
doi: 10.1159/000351459.
Luminex® and Its Applications for Solid
Organ Transplantation,
Hematopoietic Stem Cell Transplantation,
and Transfusion – PMC (nih.gov)
Wehmeier C, Hönger G, Schaub S. Caveats of HLA antibody detection by solid-phase assays.
Transpl Int. 2020 Jan;33(1):18-29.
doi: 10.1111/tri.13484.
Caveats of HLA antibody detection
by solid‐phase assays (wiley.com)
Betjes MGH, Sablik KS, Otten HG, Roelen DL, Claas FH, de Weerd A. Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts.
J Transplant. 2020 Jan 29;2020:5694670.
doi: 10.1155/2020/5694670.
JTRANS2020-5694670.pdf (nih.gov)
Gloor JM, Winters JL, Cornell LD, Fix LA, DeGoey SR, Knauer RM, Cosio FG, Gandhi MJ, Kremers W, Stegall MD. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.
Am J Transplant. 2010 Mar;10(3):582-9.
doi: 10.1111/j.1600-6143.2009.02985.x.
https://pubmed.ncbi.nlm.nih.gov/20121740/
Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Quantifying the risk of incompatible kidney transplantation: a multicentre study.
Am J Transplant 2014 Jul;14(7):1573-80.
doi: 10.1111/ajt.12786.
https://www.amjtransplant.org/article/
S1600-6135(22)25519-1/fulltext
Vikash Chandra Mishra and Vimarsh Raina. Enhancing Precision of the Single-antigen Bead (SAB) Assay: Considerations and Challenges.
Journal of Clinical and Translational Pathology 2024;4(1):12-17
Doi: 10.14218/JCTP.2023.00045
https://www.xiahepublishing.com/
2771-165X/JCTP-2023-00045
Tapiawala, Shruti; Jogale, Suchita; Shah, Bharat V; Raman, Anuradha. Is Lysate-based Human Leukocyte Antigen Crossmatch a Reliable Method to Contraindicate a Transplant?
Indian Journal of Transplantation 17(3):p 363-367, Jul–Sep 2023
DOI: 10.4103/ijot.ijot_53_23
https://journals.lww.com/ijjt/fulltext/2023/17030/
is_lysate_based_human_leukocyte_
antigen_crossmatch.17.aspx
Billen EV, Voorter CE, Christiaans MH, van den Berg-Loonen EM. Luminex donor-specific crossmatches.
Tissue Antigens. 2008 Jun;71(6):507-13
Doi: 10.1111/j.1399-0039.2008.01032.x
https://onlinelibrary.wiley.com/doi/
10.1111/j.1399-0039.2008.01032.x
Chacko MP, Augustin A, David VG, Valson AT, Daniel D. Non-specific positivity on the Luminex crossmatch assay for anti-human leukocyte antigen antibodies due to antibodies directed against antibody-coated beads.
Indian J Nephrol. 2016 Mar-Apr;26(2):134-7.
Doi: 10.4103/0971-4065.159305
https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC4795430/
Chowdhry M, Makroo RN, Thakur Y, Sharma V, Singh M, Kumar M. The good, the bad and the ugly of Luminex donor-specific crossmatch.
HLA. 2018 Jun;91(6):501-506.
Doi: https://doi.org/10.1111/tan.13239
https://onlinelibrary.wiley.com/doi/
10.1111/tan.13239
Peräsaari , J P , Jaatinen , T & Merenmies , J 2018 , ‘ Donor-specific HLA antibodies in
predicting crossmatch outcome : Comparison of three different laboratory techniques ‘,
Transplant Immunology, vol. 46, pp. 23-28.
DOI: https://doi.org/10.1016/j.trim.2017.11.002
https://www.clinicalkey.com/#!/content/
playContent/1-s2.0-S0966327417301168?
returnurl=https%3A%2F%2Flinkinghub.elsevier.com
%2Fretrieve%2Fpii%2FS096632741730
1168%3Fshowall%3Dtrue&referrer=
https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
Tait BD, Hudson F, Cantwell L, Brewin G, Holdsworth R, Bennett G, Jose M. Review article: Luminex technology for HLA antibody detection in organ transplantation.
Nephrology (Carlton). 2009 Apr;14(2):247-54.
DOI: 10.1111/j.1440-1797.2008.01074.x.
Review article: Luminex technology
for HLA antibody detection in
organ transplantation – TAIT – 2009 –
Nephrology – Wiley Online Library
Bhaskaran MC, Heidt S, Muthukumar T. Principles of Virtual Crossmatch Testing for Kidney Transplantation.
Kidney Int Rep. 2022 Mar 15;7(6):1179-1188.
DOI: 10.1016/j.ekir.2022.03.006.
Principles of Virtual Crossmatch Testing for Kidney Transplantation (nih.gov)
Johnson CP, Schiller JJ, Zhu YR, Hariharan S, Roza AM, Cronin DC, Shames BD, Ellis TM. Renal Transplantation With Final Allocation Based on the Virtual Crossmatch.
Am J Transplant. 2016 May;16(5):1503-15.
DOI: 10.1111/ajt.13606.
Renal Transplantation With Final Allocation Based on the Virtual Crossmatch – ScienceDirect
Jaramillo, Andrés PhD1; Reddy, K. Sudhakar MBBS2; Heilman, Raymond L. MD3. Using the Virtual Crossmatch to Allow for Safer and More Efficient Kidney Transplantation of Highly Sensitized Patients.
Transplantation 104(6):p 1121-1122, June 2020.
DOI: 10.1097/TP.0000000000002925
Using the Virtual Crossmatch to Allow for Safer and More Eff… : Transplantation (lww.com)
Frans H.J. Claas, Sebastiaan Heidt. Virtual crossmatching for deceased donor transplantation becomes reality.
CONTROVERSIES IN NEPHROLOGY | POINT| VOLUME 97, ISSUE 4, P657-659,
DOI: https://doi.org/10.1016/j.kint.2020.01.024
Virtual crossmatching for deceased donor transplantation
becomes reality – Kidney International (kidney-international.org)
Nishikawa, K., Masui, S. and Ishida, H. (2023), Virtual crossmatching and epitope analysis in kidney transplantation: What the physician involved in kidney transplantation should know?
Int. J. Urol., 30: 7-19.
DOI: https://doi.org/10.1111/iju.15059
Virtual crossmatching and epitope analysis in kidney transplantation:
What the physician involved in kidney transplantation should know? (wiley.com)
Rao, Prakash; Deo, Dayanand; Marchioni, Misty; Harris, Patricia. 117.4: The virtual crossmatch: A useful tool to improve organ allocation.
Transplantation 103(11S):p S12, November 2019.
DOI: 10.1097/01.tp.0000611600.66857.da
117.4: The virtual crossmatch: A useful tool to improve orga… : Transplantation (lww.com)
Duquesnoy RJ. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. An alternative strategy to increase the number of compatible donors for highly sensitised patients.
Hum Immunol. 2002 May;63(5):339-52.
Doi: 10.1097/01.TP.0000055097.58209.83
https://www.sciencedirect.com/science/article/
abs/pii/S0198885902003828?via%3Dihub
Cai J, Terasaki PI. Post transplant antibody monitoring and HLA antibody epitope identification.
Curr Opin Immunol. 2008 Oct;20(5):602-6.
Doi: http://dx.doi.org/10.1016/j.coi.2008.07.008
https://www.sciencedirect.com/science/
article/abs/pii/S095279150800126X?via%3Dihub
Sanchez-Trincado JL, Gomez-Perosanz M, Reche PA. Fundamentals and methods for T- and B-cell epitope prediction.
J Immunol Res. 2017;2017: 2680160.
Doi: https://doi.org/10.1155/2017/2680160
https://www.hindawi.com/journals/jir/2017/2680160/
Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL. Epitope load identifies kidney transplant recipients at risk of allosensitization following minimisation of immunosuppresion.
Kidney Int. 2019 Jun; 95(6):1471-1485.
Doi: https://doi.org/10.1016/j.kint.2018.12.029
https://www.kidney-international.org/article/
S0085-2538(19)30115-2/fulltext
Daniëls L, Naesens M, Bosmans JL, Abramowicz D, Nagler E, Van Laecke S, Peeters P, Kuypers D, Emonds MP. The Clinical Significance of Epitope mismatch load in kidney transplantation: A multicentre study.
Transpl Immunol. 2018 Oct;50:55-59.
Doi: https://doi.org/10.1016/j.trim.2018.06.006
https://www.sciencedirect.com/science/
article/abs/pii/S0966327418300571?via%3Dihub
Bezstarosti S, Kramer CSM, Claas FHJ, de Fijter JW, Reinders MEJ, Heidt S. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
Hum Immunol. 2022 Mar;83(3):256-263.
DOI: 10.1016/j.humimm.2021.12.002
https://linkinghub.elsevier.com/retrieve/
pii/S0198-8859(21)00292-5
Tambur AR (2018) HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details.
Front. Immunol. 9:2010.
DOI: 10.3389/fimmu.2018.02010
HLA-Epitope Matching or Eplet Risk Stratification:
The Devil Is in the Details – PMC (nih.gov)
Kumru Sahin G, Unterrainer C, Süsal C. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
Transplant Rev (Orlando). 2020 Apr;34(2):100533.
DOI: 10.1016/j.trre.2020.100533.
Critical evaluation of a possible role of HLA epitope
matching in kidney transplantation – ClinicalKey
Koothradan, Suhana; Elyas, K. K.*. Immunoinformatic Evaluation of the Cross-presentation of Donor Major Histocompatibility Derived Epitopes by Recipient Major Histocompatibility Class I Molecules in Transplantation Rejection.
Indian Journal of Transplantation 17(4):p 418-424, Oct–Dec 2023.
DOI: 10.4103/ijot.ijot_4_22
Immunoinformatic Evaluation of the Cross-presentation
of Don… : Indian Journal of Transplantation (lww.com)
Zhang Q, Reed EF. The importance of non-HLA antibodies in transplantation.
Nat Rev Nephrol. 2016 Aug;12(8):484-95
Doi: 10.1038/nrneph.2016.88.
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5669045/pdf/nihms891743.pdf
Sorohan BM, Baston C, Tacu D, Bucșa C, Țincu C, Vizireanu P, Sinescu I, Constantinescu I. Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights.
Biomedicines. 2022 Jun 25;10(7):1506.
DOI: 10.3390/biomedicines10071506.
https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC9312985/pdf/biomedicines-10-01506.pdf
Crespo M, Llinàs-Mallol L, Redondo-Pacho´ n D, Butler C, Gimeno J, Pe´ rez-Sa´ ez MJ, Burballa C, Buxeda A, Arias-Cabrales C, Folgueiras M, Sanz-Ureña S, Valenzuela NM,
Reed EF and Pascual J (2021) Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
Front. Immunol. 12:703457.
doi: 10.3389/fimmu.2021.703457
file:///C:/Users/Suchita/Downloads/fimmu-12-703457-1.pdf
Roman Reindl-Schwaighofer, Andreas Heinzel, Guido A. Gualdoni, Laurent Mesnard, Frans H.J. Claas, Rainer Oberbauer. Novel insights into non-HLA alloimmunity in kidney transplantation
Humoral Immunity in Transplantation, Volume33, Issue 1;January 2020:Pages 5-17
DOI: https://doi.org/10.1111/tri.13546
https://onlinelibrary.wiley.com/doi/10.1111/tri.13546
Ming Y, Hu J, Luo Q, Ding X, Luo W, Zhuang Q, Zou Y. Acute Antibody-Mediated Rejection in Presence of MICA-DSA and Successful Renal Re-Transplant with Negative-MICA Virtual Crossmatch.
PLoS One. 2015 May 29;10(5):e0127861.
doi: 10.1371/journal.pone.0127861.
Acute Antibody-Mediated Rejection in Presence of MICA-DSA
and Successful Renal Re-Transplant with
Negative-MICA Virtual Crossmatch (nih.gov)
Zhang Q, Reed EF. The importance of non-HLA antibodies in transplantation.
Nat Rev Nephrol. 2016 Aug;12(8):484-95.
doi: 10.1038/nrneph.2016.88.
The importance of non-HLA antibodies
in transplantation – PMC (nih.gov)
Philogene MC, Jackson AM. Non-HLA antibodies in transplantation: when do they matter?
Curr Opin Organ Transplant. 2016 Aug;21(4):427-32.
doi: 10.1097/MOT.0000000000000335.
Non-HLA antibodies in transplantation: when do they matter?
Current Opinion in Organ Transplantation (lww.com)
Anatoli Kustanovich, Ruth Schwartz, Tamar Peretz & Albert Grinshpun (2019) Life and death of circulating cell-free DNA
Cancer Biology & Therapy, 20:8, 1057-1067,
DOI: 10.1080/15384047.2019.1598759
Full article: Life and death of circulating
cell-free DNA (tandfonline.com)
Sandhya Bansal, Timothy Fleming, Thalachallour Mohanakumar. The detection of donor-derived cell-free DNA may serve as a biomarker for the early detection of chronic lung allograft dysfunction.
E Bio Medicine 40 (2019) 13–14
DOI: https://doi.org/10.1016/j.ebiom.2018.12.029.
The detection of donor-derived cell-free DNA may serve
as a biomarker for the early detection of chronic lung
allograft dysfunction (nih.gov)
R. K. Seeto, J. N. Fleming, S. Dholakia, B. L. Dale. Understanding and using AlloSure donor derived cell-free DNA
Biophys Rev. 2020 Aug;12(4):917-924.
DOI: 10.1007/s12551-020-00713-5.
Understanding and using AlloSure
donor derived cell-free DNA (nih.gov)
Kumar N, Tandon A, Rana R, Rana DS, Bhalla AK, Gupta A, Sachdeva MP, Huirem RS, Chauhan K, Yashavarddhan MH, Basnal A, Gupta R, Mallick PK, Ganguly NK. Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population.
Diagnostics (Basel). 2023 Nov 27;13(23):3540.
DOI: 10.3390/diagnostics13233540.
ncbi.nlm.nih.gov/pmc/articles/
PMC10706139/pdf/diagnostics-13-03540.pdf
Obrișcă, B., Butiu, M., Sibulesky, L. et al. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation.
Sci Rep 12, 15061 (2022).
DOI: https://doi.org/10.1038/s41598-022-19017-7
https://www.nature.com/articles/s41598-022-19017-7#citeas
Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators. Cell-Free DNA and Active Rejection in Kidney Allografts.
J Am Soc Nephrol. 2017 Jul;28(7):2221-2232.
DOI: 10.1681/ASN.2016091034
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491290/
Michael Oellerich, Karen Sherwood, Paul Keown, Ekkehard Schütz, Julia Beck, Johannes Stegbauer, Lars Christian Rump & Philip D. Walson. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury
Nature Reviews Nephrology volume 17, pages591–603 (2021)
DOI: 10.1038/s41581-021-00428-0.
https://www.nature.com/articles/s41581-021-00428-0
Kumar, N.; Rana, R.; Rana, D.S.; Gupta, A.; Sachdeva, M.P. Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future.
Transplantology 2021, 2, 348-361.
DOI: https://doi.org/10.3390/transplantology2030034
https://www.mdpi.com/2673-3943/2/3/34
Lihong Bu, Gaurav Gupta, Akshta Pai, Sanjiv Anand, Erik Stites, Irfan Moinuddin, Victor Bowers, Pranjal Jain, David A. Axelrod, Matthew R. Weir, Theresa K. Wolf-Doty, Jijiao Zeng, Wenlan Tian, Kunbin Qu, Robert Woodward, Sham Dholakia, Aleskandra De Golovine, Jonathan S. Bromberg, Haris Murad, Tarek Alhamad. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
Clinical Investigation| Volume 101, ISSUE 4, P793-803, April 2022
DOI: https://doi.org/10.1016/j.kint.2021.11.034
https://www.kidney-international.org/
article/S0085-2538(21)01168-6/fulltext
Howard M. Gebel, Robert A. Bray. Laboratory assessment of HLA antibodies circa 2006: Making sense of sensitivity.
Transplantation Reviews Volume 20, Issue 4, October 2006, Pages 189-194
doi: https://doi.org/10.1016/j.trre.2006.07.006
https://www.sciencedirect.com/science/
article/abs/pii/S0955470X06000917
William Lemieux, Hossein Mohammadhassanzadeh, William Klement, Claude Daniel, Ruth Sapir-Pichhadze. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimising compatibility of HLA eplets in transplantation.
Inter Jour Immunogen April 2021 Volume48, Issue2:Pages 135-144
Doi:https://doi.org/10.1111/iji.12525
https://onlinelibrary.wiley.com/
doi/full/10.1111/iji.12525
Understanding the HLA system in Organ transplantation- Dr. Shruti Tapiawala
Understanding the HLA System in Organ Transplantation:
Dr. Shruti Tapiawala (Series No.51)
Basics of pre-transplant immunology work-up – Dr Shruti Tapiawala
https://youtube.com/watch?v=4mKJvYJPBB8&feature=shared
Immunological risk assessment for Kidney transplant recipients- Dr. M.K. Phanish
Immunological assissment of KTX
Immunological work-up of Kidney Transplant- Dr. Ajay Kher
Ajay Kher Immunological workup of kidney transplant recipient
Donor Specific Antibodies: Dr. Muthu Kumar
https://www.youtube.com/watch?v=G651ANvzAvQ
Transplant Immunology: Dr. AJ Norin
https://youtu.be/R8Bzz6l4obg?feature=shared
Madras Medical Mission- Immunology- CME : Part-1:
MMM Immunology CME June 2023 – Part 1
Madras Medical Mission- Immunology- CME: Part-2:
MMM Immunology CME June 2023 – Part 2
Recording from Transplant Immunology Simplified – 2023, Mumbai
Novel Transplant Biomarker: Dr Vikas Dharnidharka
https://drive.google.com/file/d/1T7kj
WNx2BEp7PL0H_Ga-ZnORGSCIkUWD/view?usp=drivesdk
Nephrocon – June 7, 2024
Elaborate discussion on Approach to a failing graft by Dr Shruti Tapiawala, Dr Georgi Abraham & Dr Shrinivas Ambike.
https://youtube.com/@nephrocon?si=CykWkcmaCDZv6F5Z
Keywords – Transplant immunology, kidney transplant, Immune Response, Immunosuppression, risk of rejection, HLA antibody testing, CDC crossmatch, FLOW CYTOMETRY, recipient’s immune system, Antibodies, HLA system, Immunological work-up for transplant.
